Barclays’s Opko Health OPK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $149K | Sell |
99,596
-38,704
| -28% | -$49.4K | ﹤0.01% | 3867 |
|
|
2026
Q1 | $158K | Sell |
138,300
-524,936
| -79% | -$646K | ﹤0.01% | 3826 |
|
|
2025
Q4 | $836K | Buy |
663,236
+75,483
| +13% | +$105K | ﹤0.01% | 3561 |
|
|
2025
Q3 | $911K | Sell |
587,753
-76,654
| -12% | -$105K | ﹤0.01% | 3419 |
|
|
2025
Q2 | $877K | Buy |
664,407
+272,416
| +69% | +$372K | ﹤0.01% | 3425 |
|
|
2025
Q1 | $651K | Sell |
391,991
-524,377
| -57% | -$864K | ﹤0.01% | 3359 |
|
|
2024
Q4 | $1.35M | Buy |
916,368
+373,032
| +69% | +$570K | ﹤0.01% | 3176 |
|
|
2024
Q3 | $810K | Buy |
543,336
+329,870
| +155% | +$490K | ﹤0.01% | 3499 |
|
|
2024
Q2 | $267K | Sell |
213,466
-230,646
| -52% | -$299K | ﹤0.01% | 3407 |
|
|
2024
Q1 | $533K | Sell |
444,112
-323,966
| -42% | -$324K | ﹤0.01% | 3549 |
|
|
2023
Q4 | $1.16M | Buy |
768,078
+579,657
| +308% | +$838K | ﹤0.01% | 3327 |
|
|
2023
Q3 | $301K | Buy |
188,421
+27,946
| +17% | +$50.9K | ﹤0.01% | 3082 |
|
|
2023
Q2 | $348K | Sell |
160,475
-44,595
| -22% | -$69.8K | ﹤0.01% | 2965 |
|
|
2023
Q1 | $299K | Buy |
205,070
+96,664
| +89% | +$124K | ﹤0.01% | 3578 |
|
|
2022
Q4 | $136K | Buy |
108,406
+91,288
| +533% | +$144K | ﹤0.01% | 4054 |
|
|
2022
Q3 | $32K | Sell |
17,118
-40,501
| -70% | -$95.7K | ﹤0.01% | 3917 |
|
|
2022
Q2 | $146K | Sell |
57,619
-9,291
| -14% | -$27.1K | ﹤0.01% | 3590 |
|
|
2022
Q1 | $230K | Sell |
66,910
-438,103
| -87% | -$1.55M | ﹤0.01% | 3333 |
|
|
2021
Q4 | $2.43M | Buy |
505,013
+286,073
| +131% | +$1.16M | ﹤0.01% | 2252 |
|
|
2021
Q3 | $799K | Buy |
218,940
+108,746
| +99% | +$405K | ﹤0.01% | 2913 |
|
|
2021
Q2 | $446K | Sell |
110,194
-285,599
| -72% | -$1.12M | ﹤0.01% | 3142 |
|
|
2021
Q1 | $1.7M | Buy |
395,793
+233,012
| +143% | +$1.11M | ﹤0.01% | 2431 |
|
|
2020
Q4 | $643K | Sell |
162,781
-21,483
| -12% | -$89.7K | ﹤0.01% | 3080 |
|
|
2020
Q3 | $680K | Sell |
184,264
-67,812
| -27% | -$286K | ﹤0.01% | 2995 |
|
|
2020
Q2 | $860K | Buy |
252,076
+123,961
| +97% | +$278K | ﹤0.01% | 2890 |
|
|
2020
Q1 | $172K | Sell |
128,115
-339,444
| -73% | -$532K | ﹤0.01% | 4420 |
|
|
2019
Q4 | $688K | Buy |
467,559
+168,906
| +57% | +$283K | ﹤0.01% | 4015 |
|
|
2019
Q3 | $623K | Sell |
298,653
-580,758
| -66% | -$1.19M | ﹤0.01% | 4064 |
|
|
2019
Q2 | $2.15M | Buy |
879,411
+780,453
| +789% | +$1.7M | ﹤0.01% | 2816 |
|
|
2019
Q1 | $258K | Sell |
98,958
-56,882
| -37% | -$172K | ﹤0.01% | 4638 |
|
|
2018
Q4 | $468K | Sell |
155,840
-108,802
| -41% | -$369K | ﹤0.01% | 3873 |
|
|
2018
Q3 | $916K | Buy |
264,642
+42,018
| +19% | +$223K | ﹤0.01% | 3708 |
|
|
2018
Q2 | $1.05M | Buy |
222,624
+60,954
| +38% | +$231K | ﹤0.01% | 3239 |
|
|
2018
Q1 | $512K | Sell |
161,670
-3,533
| -2% | -$14.2K | ﹤0.01% | 3950 |
|
|
2017
Q4 | $809K | Sell |
165,203
-168,839
| -51% | -$980K | ﹤0.01% | 3326 |
|
|
2017
Q3 | $2.29M | Buy |
334,042
+301,287
| +920% | +$1.9M | ﹤0.01% | 2207 |
|
|
2017
Q2 | $215K | Sell |
32,755
-58,299
| -64% | -$409K | ﹤0.01% | 4302 |
|
|
2017
Q1 | $730K | Sell |
91,054
-13,901
| -13% | -$117K | ﹤0.01% | 3037 |
|
|
2016
Q4 | $977K | Sell |
104,955
-48,776
| -32% | -$505K | ﹤0.01% | 2767 |
|
|
2016
Q3 | $1.63M | Buy |
153,731
+128,765
| +516% | +$1.28M | ﹤0.01% | 2164 |
|
|
2016
Q2 | $233K | Sell |
24,966
-121,540
| -83% | -$1.23M | ﹤0.01% | 3813 |
|
|
2016
Q1 | $1.47M | Sell |
146,506
-1,793,103
| -92% | -$16.4M | ﹤0.01% | 2207 |
|
|
2015
Q4 | $19.4M | Sell |
1,939,609
-67,024
| -3% | -$672K | 0.02% | 574 |
|
|
2015
Q3 | $16.1M | Buy |
2,006,633
+1,299,606
| +184% | +$17.2M | 0.02% | 697 |
|
|
2015
Q2 | $11.3M | Buy |
707,027
+230,386
| +48% | +$3.58M | 0.01% | 957 |
|
|
2015
Q1 | $6.67M | Sell |
476,641
-79,950
| -14% | -$1.04M | 0.01% | 1343 |
|
|
2014
Q4 | $5.01M | Buy |
556,591
+304,551
| +121% | +$2.61M | ﹤0.01% | 1712 |
|
|
2014
Q3 | $2.02M | Buy |
252,040
+241,477
| +2,286% | +$2.12M | ﹤0.01% | 2658 |
|
|
2014
Q2 | $84K | Sell |
10,563
-92,633
| -90% | -$809K | ﹤0.01% | 5557 |
|
|
2014
Q1 | $929K | Buy |
103,196
+78,097
| +311% | +$685K | ﹤0.01% | 3322 |
|
|
2013
Q4 | $201K | Sell |
25,099
-59,887
| -70% | -$605K | ﹤0.01% | 5008 |
|
|
2013
Q3 | $680K | Sell |
84,986
-31,861
| -27% | -$256K | ﹤0.01% | 3773 |
|
|
2013
Q2 | $830K | Buy |
+116,847
| New | +$807K | ﹤0.01% | 3632 |
|
Other funds holding OPK
RCMNY
WCM
Barclays's OPK Position: Q2 2026 in Review
Barclays reduced its Opko Health (OPK) stake by 28% in Q2 2026, selling an estimated $49.4K and leaving 99,596 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #3867.
Barclays first reported a position in OPK in Q2 2013 and has held it in 53 quarters since. The position peaked at $19.4M in Q4 2015. 223 funds tracked by Wall St. Rank hold OPK as of Q2 2026.
- Barclays held 99,596 shares of Opko Health worth $149K as of Q2 2026.
- Barclays sold 38,704 Opko Health shares in Q2 2026, an estimated $49.4K.
- Opko Health made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3867 holding.
- Barclays first reported a position in Opko Health in Q2 2013 and has held it in 53 quarters since.
- Barclays's Opko Health position peaked at $19.4M in Q4 2015.
- 223 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.